Novel Experimental Drugs for Treatment of Multiple Myeloma
Massimo Offidani,1 Laura Corvatta,2 Sonia Morè,1 Attilio Olivieri1 1Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy; 2U.O.C. Medicina, Ospedale Profili, Fabriano, ItalyCorrespondence: Massimo Offidani Email massimo.offidani@ospedaliriuniti.marche.itA...
Saved in:
Main Authors: | Offidani M (Author), Corvatta L (Author), Morè S (Author), Olivieri A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety
by: Offidani M, et al.
Published: (2021) -
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment
by: Sonia Morè, et al.
Published: (2023) -
Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
by: Sonia Morè, et al.
Published: (2020) -
Introduction to "Immunotherapies for Multiple Myeloma"
by: Massimo Offidani, et al.
Published: (2020) -
In-hospital rehabilitation in the treatment of multiple myeloma
by: Alicja Mińko, et al.
Published: (2021)